CN109662142A - 一种酸奶汤的制备方法 - Google Patents
一种酸奶汤的制备方法 Download PDFInfo
- Publication number
- CN109662142A CN109662142A CN201910094494.7A CN201910094494A CN109662142A CN 109662142 A CN109662142 A CN 109662142A CN 201910094494 A CN201910094494 A CN 201910094494A CN 109662142 A CN109662142 A CN 109662142A
- Authority
- CN
- China
- Prior art keywords
- yoghourt
- milk
- soup
- preparation
- gauze
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013618 yogurt Nutrition 0.000 title claims abstract description 29
- 235000014347 soups Nutrition 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000008267 milk Substances 0.000 claims abstract description 37
- 235000013336 milk Nutrition 0.000 claims abstract description 37
- 210000004080 milk Anatomy 0.000 claims abstract description 37
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 20
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 10
- 239000004310 lactic acid Substances 0.000 claims abstract description 10
- 241000894006 Bacteria Species 0.000 claims abstract description 9
- 238000001816 cooling Methods 0.000 claims abstract description 8
- 238000000855 fermentation Methods 0.000 claims abstract description 7
- 241000235342 Saccharomycetes Species 0.000 claims abstract description 5
- 230000002745 absorbent Effects 0.000 claims abstract description 4
- 239000002250 absorbent Substances 0.000 claims abstract description 4
- 238000001914 filtration Methods 0.000 claims abstract description 4
- 238000009423 ventilation Methods 0.000 claims abstract description 4
- 238000007789 sealing Methods 0.000 claims abstract description 3
- 241000283690 Bos taurus Species 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 5
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 4
- 241000780272 Mammilla Species 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 230000009965 odorless effect Effects 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 230000009967 tasteless effect Effects 0.000 claims description 2
- 210000002784 stomach Anatomy 0.000 abstract description 11
- 230000013872 defecation Effects 0.000 abstract description 8
- 210000001835 viscera Anatomy 0.000 abstract description 6
- 239000006041 probiotic Substances 0.000 abstract description 4
- 235000018291 probiotics Nutrition 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 244000052616 bacterial pathogen Species 0.000 abstract description 2
- 238000009395 breeding Methods 0.000 abstract description 2
- 230000001488 breeding effect Effects 0.000 abstract description 2
- 210000000936 intestine Anatomy 0.000 abstract description 2
- 210000004185 liver Anatomy 0.000 abstract description 2
- 210000004072 lung Anatomy 0.000 abstract description 2
- 235000015111 chews Nutrition 0.000 abstract 1
- 239000003053 toxin Substances 0.000 description 7
- 231100000765 toxin Toxicity 0.000 description 7
- 239000000126 substance Substances 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000001465 calcium Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 240000004980 Rheum officinale Species 0.000 description 2
- 235000008081 Rheum officinale Nutrition 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 239000005862 Whey Substances 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 230000000529 probiotic effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- JSPNNZKWADNWHI-PNANGNLXSA-N (2r)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]heptadecanamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@H]([C@H](O)\C=C\CC\C=C(/C)CCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JSPNNZKWADNWHI-PNANGNLXSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- 108010059881 Lactase Proteins 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 229930183167 cerebroside Natural products 0.000 description 1
- RIZIAUKTHDLMQX-UHFFFAOYSA-N cerebroside D Natural products CCCCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O RIZIAUKTHDLMQX-UHFFFAOYSA-N 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 229940116108 lactase Drugs 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 208000005368 osteomalacia Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01J—MANUFACTURE OF DAIRY PRODUCTS
- A01J1/00—Devices or accessories for milking by hand
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Animal Husbandry (AREA)
- Environmental Sciences (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种酸奶汤的制备方法，包括如下步骤：取鲜牛奶适量，盛进木桶或瓦缸中，置于15℃～20℃的阴凉通风环境中，3～5天，经过自产的乳酸菌和酵母菌共同发酵，使鲜奶自然凝结，去掉凝乳上层的奶嚼口，再将凝乳倒进锅里，800℃～1000℃，温火煮40min～70min，慢慢榨取酸奶汤；将榨取的酸奶汤静放，待冷却后，脱脂纱布过滤，加热至68℃～70℃，并保持此温度30min后，急速冷却到4℃～5℃，灌瓶，密封。本发明所得的酸奶汤具有排毒保健的功能，在促进人体排便过程中实现了肝腑热、胃热、肺热的清除，帮助人体五脏六腑功能恢复正常，且酸奶汤里的益生菌能够调理肠胃菌群平衡，抑制致病菌的繁殖。
Description
技术领域
本发明涉及食品加工领域，具体涉及一种酸奶汤的制备方法。
背景技术
蒙医学中很早就有用酸奶汤治疗疾病的记载，能够舒筋活血、排毒、消食健胃、促进新陈代谢，能预防和治疗多种慢性疾病。酸奶汤之所以具有如此良好的医疗保健功能，主要是因为牛奶在微生物发酵的作用下产生了大量的生物活性物质。含有丰富的维生素和矿物质，容易被人体消化吸收。有效成份有：蛋白质、脂肪、糖、多种氨基酸、维生素、乳酸、钙以及多种矿物质等。
伴随着我们目前生存环境的不断改善，饮食无规律，想吃就吃，吃得太多，每日运动量的减少，脾胃消化液的分泌紊乱，胃肠微生物失去平衡，肠胃过于膨胀，胃壁变薄，加之胃中食物繁多，必然会刺激胃酸，导致大量分泌，易导致胃粘膜屏障的破坏而引起胃溃疡。导致越来越多肥胖症人群、亚健康人群、“三高”人群等的出现。这些人群最适合通过定期排毒，给肠胃减少压力，重塑肠道菌群来获得健康。
有些人一说起排毒，都自然而然地想到排便。排便是人体排毒的一条重要途径，但却不是唯一的途径。而排便的主要目的是要排出“宿便”。时下众多排毒类产品大多是针对胃肠道的，其排毒的主要机理在于促进排便。而一些消费者也因此片面地认为，体内有毒就表现为排便不畅，只要排便通畅就能起到排毒的作用。然而目前促排便的产品的主要成分中均含有大黄，大黄是一种含有蒽锟类成分的物质，长期服用会抑制自身的免疫力，且具有一定的副作用，主要表现为腹疼、轻度恶心等。此外，如果长期依赖以泻下方式来排毒，久而久之还有可能影响人体对某些营养的吸收，造成贫血等不良后果。
发明内容
为解决上述问题，本发明提供了一种酸奶汤的制备方法。
为实现上述目的，本发明采取的技术方案为：
一种酸奶汤的制备方法，包括如下步骤：
S1、挤奶：先用45℃温水洗干净奶牛乳头，适当按摩，使奶牛达到放松的状态后方可挤奶；
S2、取鲜牛奶适量(取奶量不得少于10Kg)，盛进木桶或瓦缸中，置于15℃～20℃的阴凉通风环境中，3～5天，经过自产的乳酸菌和酵母菌共同发酵，使鲜奶自然凝结，得凝乳；
S3、用蒸汽消毒过的勺子去掉凝乳上层的奶嚼口，再将凝乳倒进锅里，
800℃～1000℃，温火煮40min～70min，慢慢榨取酸奶汤(乳清)；
S4、将榨取的酸奶汤静放，待冷却后，脱脂纱布过滤，巴氏杀菌(将酸奶汤加热至68℃～70℃，并保持此温度30min后，急速冷却到4℃～5℃)，灌瓶，密封。
值得注意的是，纱布应符合YY0331-2002标准的要求，纱布块应柔软，无臭、无味，纱布块应折叠平整,不得有毛边、毛茬露外，纱布块灭菌采用环氧乙烷方法，应符合GB/T14233.2中的规定；环氧乙烷残留量应符合GB/T14233.1中的要求，不大于10μg/g。
本发明具有以下有益效果：
本发明所得的酸奶汤具有排毒保健的功能，在促进人体排便过程中实现了肝腑热、胃热、肺热的清除，帮助人体五脏六腑功能恢复正常，且酸奶汤里的益生菌能够调理肠胃菌群平衡，抑制致病菌的繁殖，是无毒副作用的天然保健饮料。
具体实施方式
下面结合具体实施例对本发明进行详细说明。以下实施例将有助于本领域的技术人员进一步理解本发明，但不以任何形式限制本发明。应当指出的是，对本领域的普通技术人员来说，在不脱离本发明构思的前提下，还可以做出若干变形和改进。这些都属于本发明的保护范围。
实施例1
一种酸奶汤的制备方法，包括如下步骤：
S1、挤奶：先用45℃温水洗干净奶牛乳头，适当按摩，使奶牛达到放松的状态后方可挤奶；
S2、取鲜牛奶适量(取奶量不得少于10Kg)，盛进木桶或瓦缸中，置于15℃～20℃的阴凉通风环境中，3～5天，经过自产的乳酸菌和酵母菌共同发酵，使鲜奶自然凝结，得凝乳；
S3、用蒸汽消毒过的勺子去掉凝乳上层的奶嚼口，再将凝乳倒进锅里，800℃～1000℃，温火煮40min～70min，慢慢榨取酸奶汤(乳清)；
S4、将榨取的酸奶汤静放，待冷却后，脱脂纱布过滤，将酸奶汤加热至68℃～70℃，并保持此温度30min后，急速冷却到4℃～5℃，灌瓶，密封。保存条件：2℃～8℃；保质期：7～10天。
本发明的鲜奶在发酵的过程中，会主动产生乳酸菌和酵母菌，酸奶汤里的乳酸菌在发酵过程中可以产生乳糖酶，将乳糖分解成葡萄糖和半乳糖(构成脑神经系统中脑苷脂的成分)，因此可以帮助体内缺乏乳糖分解酶的患者消化乳糖，避免乳糖不耐症的发生。同时，乳酸菌产生的有机酸可使PH降低，增加了肠道内维生素B1、B6和B12的稳定性，并且使钙、磷等元素处于易吸收的游离状态，还可防治由于缺铁、缺钙引起的贫血病和软骨病等。乳酸菌(双歧杆菌、嗜酸乳杆菌等)能够合成多种维生素，如叶酸、烟酸、维生素B1、维生素B2、维生素B6、维生素B12等，促进机体对蛋白质的消化、吸收；促进机体对钙、铁、维生素D的吸收，具有帮助消化增进食欲的功能。益生菌体可提供多种对其生长发育有益的物质，如维生素、氨基酸，淀粉酶、蛋白酶等消化酶类及其它促生长物质。大量实验证明，益生乳酸菌的使用可抑制或清除病原菌产生的毒素，如生物胺、吲哚和大肠杆菌内毒素及其它腐败物质等。乳酸菌与很多慢性胃炎、消化道疾病等消化道疾病有密切的关系。部分益生乳酸菌能抗胃酸，粘附在胃壁上皮细胞表面，通过其代谢活动抑制幽门螺旋杆菌的生长，预防胃病的发生。
以上对本发明的具体实施例进行了描述。需要理解的是，本发明并不局限于上述特定实施方式，本领域技术人员可以在权利要求的范围内做出各种变化或修改，这并不影响本发明的实质内容。在不冲突的情况下，本申请的实施例和实施例中的特征可以任意相互组合。
Claims (4)
1.一种酸奶汤的制备方法，其特征在于：包括如下步骤：
S1、挤奶：先用45℃温水洗干净奶牛乳头，适当按摩，使奶牛达到放松的状态后方可挤奶；
S2、取鲜牛奶适量，盛进木桶或瓦缸中，置于15℃～20℃的阴凉通风环境中，3～5天，经过自产的乳酸菌和酵母菌共同发酵，使鲜奶自然凝结，得凝乳；
S3、用蒸汽消毒过的勺子去掉凝乳上层的奶嚼口，再将凝乳倒进锅里，800℃～1000℃，温火煮40min～70min，慢慢榨取酸奶汤；
S4、将榨取的酸奶汤静放，待冷却后，脱脂纱布过滤，巴氏杀菌，灌瓶，密封。
2.如权利要求1所述的一种酸奶汤的制备方法，其特征在于：所述步骤S2中取奶量不得少于10Kg。
3.如权利要求1所述的一种酸奶汤的制备方法，其特征在于：纱布应符合YY0331-2002标准的要求，纱布块应柔软，无臭、无味，纱布块应折叠平整,不得有毛边、毛茬露外，纱布块灭菌采用环氧乙烷方法，应符合GB/T14233.2中的规定；环氧乙烷残留量应符合GB/T14233.1中的要求，不大于10μg/g。
4.如权利要求1所述的一种酸奶汤的制备方法，其特征在于：所述巴氏杀菌的工艺参数为：将酸奶汤加热至68℃～70℃，并保持此温度30min后，急速冷却到4℃～5℃。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910094494.7A CN109662142A (zh) | 2019-01-30 | 2019-01-30 | 一种酸奶汤的制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910094494.7A CN109662142A (zh) | 2019-01-30 | 2019-01-30 | 一种酸奶汤的制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109662142A true CN109662142A (zh) | 2019-04-23 |
Family
ID=66150095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910094494.7A Pending CN109662142A (zh) | 2019-01-30 | 2019-01-30 | 一种酸奶汤的制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109662142A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112155032A (zh) * | 2020-09-16 | 2021-01-01 | 萨仁高娃 | 酥油烙饼及其制备方法 |
-
2019
- 2019-01-30 CN CN201910094494.7A patent/CN109662142A/zh active Pending
Non-Patent Citations (4)
| Title |
|---|
| 曹凤英: "《内蒙古行知书》", 28 February 2011, 广东旅游出版社 * |
| 田明中等: "《恐龙之乡—二连浩特国家地质公园》", 31 August 2012, 中国电影出版社 * |
| 田风林: "《畜禽饲养与疫病防治》", 31 December 2018, 阳光出版社 * |
| 陈玉河主编: "《正镶白旗志》", 30 September 2004, 内蒙古文化出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112155032A (zh) * | 2020-09-16 | 2021-01-01 | 萨仁高娃 | 酥油烙饼及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Singh et al. | Probiotics: A review | |
| CN105558617A (zh) | 一种山乌珠活血破淤酸菜汤料及其生产方法 | |
| CN105249100B (zh) | 发酵果蔬汁与甜酒酿复合功能饮料的生产方法 | |
| US20160037811A1 (en) | Fruit and vegetable product for curing oral ulcer, and preparation method therefor | |
| CN107568736A (zh) | 解酒醒酒医学配方食品 | |
| CN104738624A (zh) | 一种神经衰弱、健忘失眠的营养保健食品 | |
| US20060045924A1 (en) | Dried fruit composition with laxative effects and method for administration thereof | |
| CN106360420A (zh) | 一种发酵型醋蛋液的制备方法 | |
| CN104172330A (zh) | 一种心脑血管保健果蔬汁 | |
| CN108968037A (zh) | 老年痴呆症全营养配方食品 | |
| CN104304578A (zh) | 一种火龙果菌茶 | |
| CN105614860A (zh) | 一种益生菌复配低聚肽降尿酸营养补充剂 | |
| CN107996936A (zh) | 一种可改善胃部健康问题的固体饮料 | |
| CN107319550A (zh) | 脑外伤全营养配方食品 | |
| CN104187643A (zh) | 阳虚体质全营养配方食品 | |
| CN103798494A (zh) | 健胃益脾红茶菌山楂糕及其制作方法 | |
| CN109662142A (zh) | 一种酸奶汤的制备方法 | |
| CN107853615A (zh) | 一种发酵型醋蛋咀嚼片及其制备方法 | |
| CN101190279A (zh) | 一种健胃、止泻中药饮料 | |
| CN104187650A (zh) | 特禀体质全营养配方食品 | |
| CN105558621A (zh) | 一种长青草祛风止咳酸菜汤料及其生产方法 | |
| CN105558608A (zh) | 一种荆芥祛风解表酸菜汤料及其生产方法 | |
| CN108244623A (zh) | 一种消食健脾胃糕点及其制备方法 | |
| CN107050106A (zh) | 一种用于预防和治疗慢性咽炎的含片 | |
| RU2826972C1 (ru) | Применение кисломолочных продуктов, ферментированных пробиотическими штаммами бактерий bacillus subtilis тнп-3 и bacillus subtilis тнп-5, при лечении больных туберкулезом легких |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190423 |